-
Role of Age-Associated Metabolic Changes in Alzheimer's Disease (AD) (R01)
(PAR-17-031)
National Institute on Aging
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Translational Bioinformatics Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease (R01)
(PAR-17-032)
National Institute on Aging
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Integrative Research to Understand the Impact of Sex Differences on the Molecular Determinants of AD Risk and Responsiveness to Treatment (R01)
(PAR-17-033)
National Institute on Aging
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
NIDDK Exploratory Clinical Trials for Small Business (R44)
(PAR-17-034)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization.
-
Platform Delivery Technologies for Nucleic Acid Therapeutics (R43/R44)
(PAR-17-035)
National Center for Advancing Translational Sciences
National Center for Advancing Translational Sciences
National Institute of Allergy and Infectious Diseases
National Institute of Biomedical Imaging and Bioengineering
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization.
-
Platform Delivery Technologies for Nucleic Acid Therapeutics (R41/R42)
(PAR-17-036)
National Center for Advancing Translational Sciences
National Center for Advancing Translational Sciences
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): Standard dates apply by 5:00 PM local time of applicant organization.
-
Clarifying the Relationship between Delirium and Alzheimers Disease and Related Dementias (R21/R33)
(PAR-17-037)
National Institute on Aging
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Clarifying the Relationship between Delirium and Alzheimers Disease and Related Dementias (R01)
(PAR-17-038)
National Institute on Aging
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Comparative Biology of Neurodegeneration (R21)
(PAR-17-039)
National Institute on Aging
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Exosomes: From Biogenesis and Secretion to the Early Pathogenesis of Alzheimer's Disease (R01)
(RFA-AG-17-051)
National Institute on Aging
Application Receipt Date(s): February 3, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
-
Understanding the Effects of ApoE2 on the Interaction between Aging and Alzheimers Disease (R01)
(RFA-AG-17-056)
National Institute on Aging
Application Receipt Date(s): February 10, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
-
Multimorbidity in Alzheimers Disease Impacts Choice of Ancillary Treatments (R21/R33)
(RFA-AG-17-059)
National Institute on Aging
Application Receipt Date(s): January 12, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
-
Multimorbidity in Alzheimers Disease Impacts Choice of Ancillary Treatments (R33)
(RFA-AG-17-060)
National Institute on Aging
Application Receipt Date(s): January 12, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
-
Research Centers for Population-based Research to Optimize Cancer Screening (PROSPR) Initiative (UM1)
(RFA-CA-16-016)
National Cancer Institute
Application Receipt Date(s): February 9, 2017, by 5:00 PM local time of applicant organization. All applications allowed for this funding opportunity announcement are due on this date.
No late applications will be accepted for the Funding Opportunity
Announcement.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Coordinating Center for Population-based Research to Optimize Cancer Screening (PROSPR) (U24)
(RFA-CA-16-017)
National Cancer Institute
Application Receipt Date(s): February 9, 2017, by 5:00 PM local time of applicant organization. All applications allowed for this funding opportunity announcement are due on this date.
No late applications will be accepted for the Funding Opportunity
Announcement.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Pilot Clinical Trials in Pediatric Chronic Kidney Disease Participating Clinical Centers (U01)
(RFA-DK-16-018)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): February 17, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
-
Pilot Clinical Trials in Pediatric Chronic Kidney Disease Data Coordinating Center (U24)
(RFA-DK-16-035)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): February 17, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
-
NIH Revision Awards for Creating Virtual Consortium for Translational/Transdisciplinary Environmental Research (ViCTER)(R01)
(RFA-ES-17-002)
National Institute of Environmental Health Sciences
Application Receipt Date(s): March 7, 2017; March 6, 2018; March 6, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Circadian Mechanisms Contributing to Obesity, Diabetes Metabolism, and Underlying Heart, Lung, and Blood Disorders (R01)
(RFA-HL-17-020)
National Heart, Lung, and Blood Institute
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): March 14, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.